Microbiology & Infectious Diseases

Explore how a biopreparedness map can strengthen special pathogens readiness, mass gathering planning, and frontline outbreak response…

The treatment options for Clostridioides difficile are changing, with two FDA-approved microbiota products, discontinued therapies, and…

Two leading experts discuss the COVID-19 post-exposure prevention gap, especially in high-contact and group care settings among vulnerable…

A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, a term…

Expert insights from Dr Hana F. Safah on treating invasive fungal infections in hematology/oncology patients…

The burden of tickborne diseases in the US more than doubled between 2004–2016, with >491,000 cases reported during this period…

Histoplasmosis is a fungal infection caused by Histoplasma capsulatum,1-3 a dimorphic fungus1,3-6 belonging to the family Ajellomycetaceae…